Latest Shareholder Approvals News

Provaris Energy has raised $1 million through a share placement to fund key 2026 development milestones in hydrogen and liquid CO2 storage, reinforcing its technical progress and partnerships.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Tāiko Critical Minerals has locked in a key 304-hectare land parcel for its Barrytown project with an $18 million conditional purchase, clearing a major hurdle towards mining and production targets.

Ryder Capital Limited has launched a fresh on-market buy-back program targeting up to 8 million ordinary shares, extending its capital management strategy through mid-2027 without requiring shareholder approval.

Adherium Limited secured shareholder approval for all resolutions at its June 19, 2026 Extraordinary General Meeting, including a pivotal 1-for-100 share consolidation and approvals tied to recent capital raises and director participation.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

CONNEQT Health has raised A$5.5 million through a two-tranche placement at a 15.4% discount, backed by key shareholders, to accelerate its commercial expansion and product development.

International Graphite Limited (ASX: IG6) has raised $4 million to fast-track its graphite processing ventures in Europe and Western Australia, supported by a UK critical minerals fund and existing shareholders.

Jindalee Lithium has completed a A$2.4 million entitlement offer, issuing over 5.2 million shares with attaching options to fund its McDermitt Lithium Project and support a NASDAQ listing.

Acrow Limited has secured $70 million through a fully underwritten two-tranche placement to acquire Ausgroup Industrial Services and Preston SuperDeck, boosting its FY27 revenue and EBITDA guidance significantly.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Finder Energy has issued 12 million shares at 50 cents each, raising $6 million from Amplus Energy and Longreach Capital following shareholder approval.